fdaApril 10, 2019
Read Our Digital Health Innovation Action Plan
The Digital Health Innovation Action Plan outlines our efforts to reimagine the FDA’s approach to ensuring all Americans have timely access to high-quality, safe and effective digital health products. As part of this plan, we committed to several key goals, including increasing the number and expertise of digital health staff at the FDA, launching the digital health software precertification pilot program ("Pre-Cert") and issuing guidance to modernize our policies.
Commissioner’s Statement: Advancing new digital health policies to encourage innovation, bring efficiency and modernization to regulation
The broad scope of digital health includes categories such as mobile health (mHealth), health information technology (IT), wearable devices, telehealth and telemedicine, and personalized medicine.
Providers and other stakeholders are using digital health in their efforts to:
Reduce inefficiencies,
Improve access,
Reduce costs,
Increase quality, and,
Make medicine more personalized for patients.
Patients and consumers can use digital health to better manage and track their health and wellness related activities.
The use of technologies such as smart phones, social networks and internet applications is not only changing the way we communicate, but is also providing innovative ways for us to monitor our health and well-being and giving us greater access to information. Together these advancements are leading to a convergence of people, information, technology and connectivity to improve health care and health outcomes.
Why is the FDA Focusing on Digital Health?
Many medical devices now have the ability to connect to and communicate with other devices or systems. Devices that are already FDA approved or cleared are being updated to add digital features. New types of devices that already have these capabilities are being explored.
Many stakeholders are involved in digital health activities, including patients, health care practitioners, researchers, traditional medical device industry firms, and firms new to FDA regulatory requirements, such as mobile application developers.
FDA’s Center for Devices and Radiological Health is excited about these advances and the convergence of medical devices with connectivity and consumer technology. The following are topics in the digital health field on which the FDA has been working to provide clarity using practical approaches that balance benefits and risks:
Wireless Medical Devices
Mobile medical apps
Health IT
Telemedicine
Medical Device Data Systems
Medical device Interoperability
Software as a Medical Device (SaMD)
General Wellness
Cybersecurity
How is the FDA Advancing Digital Health?
The FDA's Center for Devices and Radiological Health (CDRH) has established the Digital Health Program which seeks to better protect and promote public health and provide continued regulatory clarity by:
Fostering collaborations and enhancing outreach to digital health customers, and
Developing and implementing regulatory strategies and policies for digital health technologies.
Federal Trade Commission (FTC) Mobile Health Apps Interactive Tool
If you are developing a mobile health app that collects, creates, or shares consumer information, use the tool on Federal Trade Commission’s website to find out when FDA, Federal Trade Commission (FTC) or Office of Civil Rights (OCR) laws apply:
For more information, see FTC's Press Release or visit our Mobile Medical Applications page.
Jobs in the FDA's Digital Health Program
The FDA seeks software engineers, Artificial Intelligence and Machine Learning engineers, security researchers, User interface and User Experience designers, product managers to be a part of the Digital Health team. If you are interested, email digitalhealth@fda.hhs.gov with Subject: "Resume" or call (240) 402-3196.
For more information about the duties, read the digital health job description.
Register as Visitor to CPhI China 2019!
-----------------------------------------------------------------------
Editor's Note:
To apply for becoming a contributor of En-CPhI.cn,
welcome to send your CV and sample works to us,
Email: Julia.Zhang@ubmsinoexpo.com.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: